Literature DB >> 29636376

Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.

Qingcheng Mao1, Yurong Lai1, Joanne Wang1.   

Abstract

Drug transporters are widely expressed in organs and tissue barriers throughout human and animal bodies. Studies over the last two decades have identified various ATP-binding cassette and solute carrier transporters that play critical roles in the absorption, distribution, metabolism, and elimination of drugs and xenobiotics. This special section contains more than 20 original manuscripts and reviews that cover the most recent advances in the areas of drug transporter research, including the basic biology and function of transporters, expression of drug transporters in organ and tissue barriers, the mechanisms underlying regulation of transporter expression, transporter-mediated drug disposition in animal models, and the development and utilization of new technologies in drug transporter study, as well as pharmacokinetic modeling and simulation to assess transporter involvement in drug disposition and drug-drug interactions. We believe that the topics covered in this special section will advance our understanding of the roles of transporters in drug disposition, efficacy, and safety.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29636376      PMCID: PMC5896374          DOI: 10.1124/dmd.118.081356

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  58 in total

1.  General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  D E Mager; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-12       Impact factor: 2.745

Review 2.  Transporters and drug therapy: implications for drug disposition and disease.

Authors:  Richard H Ho; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2005-09       Impact factor: 6.875

Review 3.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

Review 4.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

5.  Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.

Authors:  Hannah M Jones; Hugh A Barton; Yurong Lai; Yi-An Bi; Emi Kimoto; Sarah Kempshall; Sonya C Tate; Ayman El-Kattan; J Brian Houston; Aleksandra Galetin; Katherine S Fenner
Journal:  Drug Metab Dispos       Date:  2012-02-16       Impact factor: 3.922

6.  Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney.

Authors:  Harunobu Tahara; Masayuki Shono; Hiroyuki Kusuhara; Hajime Kinoshita; Eiichi Fuse; Akira Takadate; Masaki Otagiri; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-04-07       Impact factor: 4.200

7.  Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.

Authors:  Ryan E Morgan; Michael Trauner; Carlo J van Staden; Paul H Lee; Bharath Ramachandran; Michael Eschenberg; Cynthia A Afshari; Charles W Qualls; Ruth Lightfoot-Dunn; Hisham K Hamadeh
Journal:  Toxicol Sci       Date:  2010-09-09       Impact factor: 4.849

Review 8.  Cynomolgus monkey CYPs: a comparison with human CYPs.

Authors:  K Iwasaki; Y Uno
Journal:  Xenobiotica       Date:  2009-08       Impact factor: 1.908

9.  Molecular cloning and functional characterization of cynomolgus monkey multidrug resistance-associated protein 2 (MRP2).

Authors:  Masa Yasunaga; Masaaki Takemura; Kyoko Fujita; Hikaru Yabuuchi; Morimasa Wada
Journal:  Eur J Pharm Sci       Date:  2008-08-09       Impact factor: 4.384

Review 10.  BCRP/ABCG2 in the placenta: expression, function and regulation.

Authors:  Qingcheng Mao
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

View more
  10 in total

1.  Isoflavones in Soybean as a Daily Nutrient: The Mechanisms of Action and How They Alter the Pharmacokinetics of Drugs.

Authors:  Amelia Soyata; Aliya Nur Hasanah; Taofik Rusdiana
Journal:  Turk J Pharm Sci       Date:  2021-12-31

Review 2.  Application of CRISPR-Cas9 System to Study Biological Barriers to Drug Delivery.

Authors:  Ji He; Riya Biswas; Piyush Bugde; Jiawei Li; Dong-Xu Liu; Yan Li
Journal:  Pharmaceutics       Date:  2022-04-20       Impact factor: 6.525

3.  In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.

Authors:  Sunjoo Kim; Won-Gu Choi; Mihwa Kwon; Sowon Lee; Yong-Yeon Cho; Joo Young Lee; Han Chang Kang; Im-Sook Song; Hye Suk Lee
Journal:  Molecules       Date:  2019-08-19       Impact factor: 4.411

4.  Need for alternatives to animals in experimentation: An Indian perspective.

Authors:  Soumya Swaminathan; Vijay Kumar; Rajni Kaul
Journal:  Indian J Med Res       Date:  2019-05       Impact factor: 2.375

5.  Yeast Double Transporter Gene Deletion Library for Identification of Xenobiotic Carriers in Low or High Throughput.

Authors:  Ludimila Dias Almeida; Ali Salim Faraj Silva; Daniel Calixto Mota; Adrielle Ayumi Vasconcelos; Antônio Pedro Camargo; Gabriel Silva Pires; Monique Furlan; Helena Martins Ribeiro da Cunha Freire; Angélica Hollunder Klippel; Suélen Fernandes Silva; Cleslei Fernando Zanelli; Marcelo Falsarella Carazzolle; Stephen G Oliver; Elizabeth Bilsland
Journal:  mBio       Date:  2021-12-14       Impact factor: 7.786

6.  Molecular Properties of Drugs Handled by Kidney OATs and Liver OATPs Revealed by Chemoinformatics and Machine Learning: Implications for Kidney and Liver Disease.

Authors:  Anisha K Nigam; Anupam A Ojha; Julia G Li; Da Shi; Vibha Bhatnagar; Kabir B Nigam; Ruben Abagyan; Sanjay K Nigam
Journal:  Pharmaceutics       Date:  2021-10-18       Impact factor: 6.321

Review 7.  Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development.

Authors:  Yurong Lai; Xiaoyan Chu; Li Di; Wei Gao; Yingying Guo; Xingrong Liu; Chuang Lu; Jialin Mao; Hong Shen; Huaping Tang; Cindy Q Xia; Lei Zhang; Xinxin Ding
Journal:  Acta Pharm Sin B       Date:  2022-03-17       Impact factor: 14.903

8.  Oleacein Intestinal Permeation and Metabolism in Rats Using an In Situ Perfusion Technique.

Authors:  Anallely López-Yerena; Maria Pérez; Anna Vallverdú-Queralt; Eleftherios Miliarakis; Rosa M Lamuela-Raventós; Elvira Escribano-Ferrer
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

Review 9.  Pharmacogenetics of Statin-Induced Myotoxicity.

Authors:  Ping Siu Kee; Paul Ken Leong Chin; Martin A Kennedy; Simran D S Maggo
Journal:  Front Genet       Date:  2020-10-16       Impact factor: 4.599

10.  In Vitro Interaction of AB-FUBINACA with Human Cytochrome P450, UDP-Glucuronosyltransferase Enzymes and Drug Transporters.

Authors:  Sunjoo Kim; Dong Kyun Kim; Yongho Shin; Ji-Hyeon Jeon; Im-Sook Song; Hye Suk Lee
Journal:  Molecules       Date:  2020-10-08       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.